Skip to main contentSkip to navigation
Sirius Investors
Torii Pharmaceutical Co., Ltd.

Torii Pharmaceutical Co., Ltd.

TRXPF
OTCHealthcare

Torii Pharmaceutical Co., Ltd. (TRXPF) Financial Metrics

This dashboard provides comprehensive financial metrics and analysis to help evaluate Torii Pharmaceutical Co., Ltd.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.

Financial Metrics Score

Valuation Metrics

Sector benchmarks: Industrials

2024
P/E Ratio
50597467.53
Weak
WeakModerateStrong
P/B Ratio
2099083.75
Weak
WeakModerateStrong
Earnings Yield
0.00%
Yield Trap
WeakModerateStrong

Profitability Health

2024
Return on Equity
4.15%
Weak
WeakModerateStrong
Operating Margin
11.25%
Moderate
WeakModerateStrong
Net Profit Margin
8.34%
Moderate
WeakModerateStrong

Growth Indicators

2024
Revenue Growth
10.59%
Strong
WeakModerateStrong
Net Income Growth
22.41%
Strong
WeakModerateStrong
EPS Growth
22.44%
Strong
WeakModerateStrong

Efficiency & Liquidity

2024
Current Ratio
5.21
Strong
WeakModerateStrong
Quick Ratio
4.43
Strong
WeakModerateStrong
Asset Turnover
0.43x
Weak
WeakModerateStrong
Inventory Turnover
2.39x
Weak
WeakModerateStrong

Cash Flow & Resilience

Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes

2024
Free Cash Flow Yield
0.00%
Weak
WeakModerateStrong
EV / Free Cash Flow
73159711.62x
Weak
WeakModerateStrong
Net Debt / EBITDA
-4.37x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.989
Strong
WeakModerateStrong
Return on Invested Capital
4.16%
Weak
WeakModerateStrong
Cash Conversion Cycle
228.22 days
Weak
WeakModerateStrong

Fortress screener guardrails

1/4 passing
  • FCF Yield > 3%
  • Net Debt / EBITDA < 1.5x
  • ROIC > 20%
  • Cash Conversion Cycle < 0 days

Financial Statements

Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for TRXPF.

View Financial Statements